» Articles » PMID: 28765083

Breast Screening for Survivors of Breast Cancer: A Systematic Review

Overview
Journal Prev Med
Specialty Public Health
Date 2017 Aug 3
PMID 28765083
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

There is a large and growing population of women who have a personal history of breast cancer (PHBC). This systematic review was undertaken to explore the outcomes of surveillance mammography in breast cancer survivors, and to examine the evidence for screening these women within an organized population-based screening program. We searched Cochrane Central Register of Controlled Trials (CENTRAL Issue 6, 2015), OVID MEDLINE and EMBASE (January 2012 to June 22, 2015) for English-language studies of surveillance of the target population. A study author extracted study outcomes, which were audited by a research assistant. One systematic review and 5 primary studies were included. These showed that surveillance mammography may reduce breast cancer-specific mortality through early/asymptomatic detection (Hazard Ratio for those without compared to with symptoms:HR: 0.64, 95% CI 0.55 - 0.74). Three studies showed that semi-annual mammography is likely not of greater benefit than annual mammography. No evidence was found to suggest that surveillance mammography for women with a PHBC should not be conducted within an organized screening program. The small evidence-base had a high level of heterogeneity in populations, interventions and outcomes. Based on this review, organized screening programs should reassess their guidelines on surveillance mammography and consider including women with a PHBC.

Citing Articles

Evolving strategies for the routine follow-up of patients with early breast cancer and the impact of COVID-19: a survey of healthcare providers.

Beltran-Bless A, Larocque G, Arnaout A, Caudrelier J, Hilton J, Alqahtani N Support Care Cancer. 2025; 33(3):232.

PMID: 40014172 DOI: 10.1007/s00520-025-09205-2.


Differences in breast cancer diagnosis by patient presentation in Ontario: a retrospective cohort study.

Habbous S, Homenauth E, Barisic A, Kandasamy S, Majpruz V, Forster K CMAJ Open. 2022; 10(2):E313-E330.

PMID: 35383035 PMC: 9259434. DOI: 10.9778/cmajo.20210254.


Breast and thyroid cancer: A multicenter study with Accrual to Clinical Trials Network.

Peckham M, Spencer H, Syed S, Armstrong W, Farwell D, Gal T J Surg Oncol. 2022; 125(8):1211-1217.

PMID: 35195923 PMC: 9106860. DOI: 10.1002/jso.26825.


The COVID-19 pandemic: An opportunity to rethink and harmonise the frequency of follow-up visits for patients with early stage breast cancer.

Surujballi J, Shah H, Hutton B, Alzahrani M, Beltran-Bless A, Shorr R Cancer Treat Rev. 2021; 97:102188.

PMID: 33813329 PMC: 7986467. DOI: 10.1016/j.ctrv.2021.102188.


Participation in breast cancer screening among breast cancer survivors -A nationwide register-based cohort study.

Larsen M, Vejborg I, Njor S Breast. 2020; 54:31-36.

PMID: 32898786 PMC: 7486472. DOI: 10.1016/j.breast.2020.08.012.